Foghorn Therapeutics (FHTX) Capital Expenditures (2019 - 2026)
Foghorn Therapeutics (FHTX) recorded Capital Expenditures of $50,000 in Q2 2026, up 127.3% from $22,000 a year earlier.
Powered by 
Analysis
Foghorn Therapeutics (FHTX) Capital Expenditures (2019 - 2026) Analysis & Trends
Starting with Q4 2019, Foghorn Therapeutics' Capital Expenditures history includes 24 quarters.
- Annual Capital Expenditures has a five-year compound annual growth rate of -68.5% (FY2020 to FY2025).
- Across earlier years, Capital Expenditures came in at $906,000 in FY2024 (-26.0%), $1.22 million in FY2023 (+1.2%), $1.21 million in FY2022 (-63.5%) and $3.31 million in FY2021 (-79.5%).
- The Q2 2026 figure is the highest quarterly Capital Expenditures since Q4 2024.
- On a year-over-year basis, Capital Expenditures rose in three of the last four quarters, with growth averaging 90.3%.
- Peak year-over-year performance for Capital Expenditures in the last five years was growth of 276.8% in Q3 2024, against a decline of 98.9% in Q4 2021 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 1.32 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 322.00 Mn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 893.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -321.00 Mn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -763.00 Mn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 513.00 Mn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 140.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 533.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 112.20 Mn |
| 10 | Foghorn Therapeutics | 206.67 Mn | -119.28 Mn | - | 50,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 50,000.00 |
| Jun 30, 2025 | 22,000.00 |
| Mar 31, 2025 | 28,000.00 |
| Dec 31, 2024 | 479,000.00 |
| Sep 30, 2024 | 309,000.00 |
| Jun 30, 2024 | 17,000.00 |
| Mar 31, 2024 | 101,000.00 |
| Dec 31, 2023 | 37,000.00 |
| Sep 30, 2023 | 82,000.00 |
| Jun 30, 2023 | 469,000.00 |
| Mar 31, 2023 | 636,000.00 |
| Dec 31, 2022 | 269,000.00 |
| Sep 30, 2022 | 330,000.00 |
| Jun 30, 2022 | 364,000.00 |
| Mar 31, 2022 | 247,000.00 |
| Dec 31, 2021 | 80,000.00 |
| Sep 30, 2021 | 230,000.00 |
| Jun 30, 2021 | 1.21 Mn |
| Mar 31, 2021 | 1.79 Mn |
| Dec 31, 2020 | 7.49 Mn |
API Access
Foghorn Therapeutics Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=FHTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "FHTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=FHTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();